Press release
CORRECTING and REPLACING -- Investigation announced for Investors in NASDAQ: CBIO shares over possible Securities Laws Violations by Catalyst Biosciences, Inc.
In a release issued earlier today by Shareholders Foundation under the same headline please note that company should read Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), and NOT Catalyst Biosciences, Inc. (NASDAQ: CBIO).The corrected release reads:
Investigation announced for Investors in NASDAQ: CPRX shares over possible Securities Laws Violations by Catalyst Pharmaceuticals, Inc.
An investigation for investors in Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) shares over potential securities laws violations by Catalyst Pharmaceuticals, Inc. was announced.
An investigation was announced concerning potential securities laws violations by Catalyst Pharmaceuticals, Inc. in connection with certain financial statements.
Investors who purchased shares of Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Catalyst Pharmaceuticals, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Coral Gables, FL based Catalyst Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases.
On October 30, 2019, Catalyst issued a press release announcing “top-line results from CMS-001, a Phase 3 study evaluating amifampridine phosphate for the symptomatic treatment of genetically confirmed Congenital Myasthenic Syndromes (CMS) in adults and children aged 2 years and above.” The press release advised investors that “[w]hile individual patient improvements were observed in some patient sub-groups, the trial did not meet its primary endpoint of subject global impression (SGI) or the secondary endpoint of muscle function measure (MFM) across all tested subtypes.”
Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) closed on November 5, 2019, at $4.64 per share.
Those who purchased shares of Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CORRECTING and REPLACING -- Investigation announced for Investors in NASDAQ: CBIO shares over possible Securities Laws Violations by Catalyst Biosciences, Inc. here
News-ID: 1862492 • Views: …
More Releases from Shareholders Foundation
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, …
A deadline is coming up on September 12, 2025in the lawsuit filed for certain investors of Biohaven Ltd. (NYSE: BHVN) over alleged securities laws violations by Biohaven Ltd.
Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2025. NYSE: BHVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc..
Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed…
More Releases for Catalyst
Cr-based Alkanes Dehydrogenation Catalyst Market 2025: Innovations, Trends, and …
Los Angeles-United State: QY Research has recently published a research report titled, "Cr-based Alkanes Dehydrogenation Catalyst - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031" assessing various factors impacting its trajectory. The market research report is a perfect tool for digging deep into critical aspects of the global Cr-based Alkanes Dehydrogenation Catalyst market and closely understanding factors that influence its growth. Our research analysts are experienced enough…
Catalyst Market Economic Drivers Factors Influencing Catalyst Market Expansion - …
In recent years, the global Catalyst Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Catalyst Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five Forces Analysis,…
Diesel Engine Catalyst Market Report 2024 - Diesel Catalyst Market Size And Grow …
"The Business Research Company recently released a comprehensive report on the Global Diesel Engine Catalyst Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Continuous Catalyst Regeneration (CCR) Catalyst Market Segmentation & Analysis, …
Los Angeles, USA: QY Research has recently unveiled a comprehensive report titled, "Global Continuous Catalyst Regeneration (CCR) Catalyst Market Report: Insights, Forecast to 2030." This detailed analysis examines the multiple elements shaping the future of the global Continuous Catalyst Regeneration (CCR) Catalyst market.
The Continuous Catalyst Regeneration (CCR) Catalyst report serves as an invaluable resource for industry players, providing precise and extensive research insights necessary for strategic decision-making. The analysts have…
Refinery Catalyst Market: Refinery Catalyst Market Projections: Innovations and …
Market Overview:
Refinery catalysts are used in petroleum refining operations to facilitate and accelerate chemical reactions for conversion of crude oil into useful petroleum products like gasoline, diesel, jet fuel etc. Without catalysts, refining processes would be inefficient or not commercially viable.
Get Sample Report with Global Industry Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/736
Major Players Are:
✤ BP Global and Royal Dutch Shell. Other key industry participants include YARA International
✤ Foster Wheeler AG
✤ OXEA GmbH
✤ W…
Global Homogeneous Catalyst Market, Global Homogeneous Catalyst Industry, Covid- …
Homogeneous catalysts such as transition metal complexes have been utilized for the chemical reactions on the biopolymers. Homogeneous catalysts were the catalysts of choice in the early days of metathesis reactions. They entailed of a transition metal compound and a non-transition metal compound, primarily organometallic as cocatalysts. Although, the homogeneous catalysts have high probable to speed up the reaction rate, augment selectivity, conversion rate, and diminish side reactions, they cannot…
